Mark L. Berch

Array ( [id] => 4728368 [patent_doc_number] => 20080207912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Method for manufacture of ceftiofur' [patent_app_type] => utility [patent_app_number] => 12/150744 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6761 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207912.pdf [firstpage_image] =>[orig_patent_app_number] => 12150744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887887 [patent_doc_number] => 20080262219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'NOVEL CRYSTAL OF 7-[2-[(2-AMINOTHIAZOL-4-YL)-2-HYDROXYIMINOACETAMIDE-3-VINYL-3-CEPHEM-4-CARBOXYLIC ACID (SYN ISOMER) AND METHOD FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/112432 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6355 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262219.pdf [firstpage_image] =>[orig_patent_app_number] => 12112432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 574520 [patent_doc_number] => 07459442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/108885 [patent_app_country] => US [patent_app_date] => 2008-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13866 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459442.pdf [firstpage_image] =>[orig_patent_app_number] => 12108885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92221 [patent_doc_number] => 07732413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/108729 [patent_app_country] => US [patent_app_date] => 2008-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12578 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732413.pdf [firstpage_image] =>[orig_patent_app_number] => 12108729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 83655 [patent_doc_number] => 07741289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/107112 [patent_app_country] => US [patent_app_date] => 2008-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13155 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741289.pdf [firstpage_image] =>[orig_patent_app_number] => 12107112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290974 [patent_doc_number] => 20090023704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Novel Compounds 737' [patent_app_type] => utility [patent_app_number] => 12/104469 [patent_app_country] => US [patent_app_date] => 2008-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29866 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023704.pdf [firstpage_image] =>[orig_patent_app_number] => 12104469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446466 [patent_doc_number] => 20090047692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'OPTICALLY-DETECTABLE ENZYME SUBSTRATES AND THEIR METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 12/099085 [patent_app_country] => US [patent_app_date] => 2008-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 51949 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047692.pdf [firstpage_image] =>[orig_patent_app_number] => 12099085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474583 [patent_doc_number] => 20090247749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'SALT FORM AND COCRYSTALS OF ADEFOVIR DIPIVOXIL AND PROCESSES FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/059321 [patent_app_country] => US [patent_app_date] => 2008-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3561 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247749.pdf [firstpage_image] =>[orig_patent_app_number] => 12059321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6591461 [patent_doc_number] => 20100130516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/593152 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7450 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130516.pdf [firstpage_image] =>[orig_patent_app_number] => 12593152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432447 [patent_doc_number] => 20100152210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/593218 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8652 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152210.pdf [firstpage_image] =>[orig_patent_app_number] => 12593218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712011 [patent_doc_number] => 20120004246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/593220 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7974 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12593220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6455395 [patent_doc_number] => 20100105705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/593269 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9722 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105705.pdf [firstpage_image] =>[orig_patent_app_number] => 12593269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629952 [patent_doc_number] => 08362024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Purinyl derivatives and their use as potassium channel modulators' [patent_app_type] => utility [patent_app_number] => 12/593194 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13556 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12593194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564728 [patent_doc_number] => 20090137581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Heterocyclic compounds and their uses' [patent_app_type] => utility [patent_app_number] => 12/079406 [patent_app_country] => US [patent_app_date] => 2008-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84988 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137581.pdf [firstpage_image] =>[orig_patent_app_number] => 12079406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6590854 [patent_doc_number] => 20100130491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => '9-SUBSTITUTED-8-OXO-ADENINE COMPOUNDS AS TOLL-LIKE RECEPTOR (TLR7 ) MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/532090 [patent_app_country] => US [patent_app_date] => 2008-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11870 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130491.pdf [firstpage_image] =>[orig_patent_app_number] => 12532090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497775 [patent_doc_number] => 20100093998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'NOVEL ADENINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/532007 [patent_app_country] => US [patent_app_date] => 2008-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39230 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093998.pdf [firstpage_image] =>[orig_patent_app_number] => 12532007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6359792 [patent_doc_number] => 20100087443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => '9-SUBSTITUTED-8-OXO-ADENINE COMPOUNDS AS TOLL-LIKE RECEPTOR (TLR7) MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/532084 [patent_app_country] => US [patent_app_date] => 2008-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14282 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087443.pdf [firstpage_image] =>[orig_patent_app_number] => 12532084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527464 [patent_doc_number] => 08044056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Adenine compound' [patent_app_type] => utility [patent_app_number] => 12/531867 [patent_app_country] => US [patent_app_date] => 2008-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17086 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044056.pdf [firstpage_image] =>[orig_patent_app_number] => 12531867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765646 [patent_doc_number] => 20080176858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'SELECTIVE ANTAGONISTS OF A2A ADENOSINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/049801 [patent_app_country] => US [patent_app_date] => 2008-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27601 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176858.pdf [firstpage_image] =>[orig_patent_app_number] => 12049801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739474 [patent_doc_number] => 20080233127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'IMIDAZOLOPYRIMIDINE ANALOGS AND THEIR USE AS PI3 KINASE AND MTOR INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/044500 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36987 [patent_no_of_claims] => 122 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233127.pdf [firstpage_image] =>[orig_patent_app_number] => 12044500 [rel_patent_id] =>[rel_patent_doc_number] =>)